390 related articles for article (PubMed ID: 9371598)
1. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains.
Tailor CS; Kabat D
J Virol; 1997 Dec; 71(12):9383-91. PubMed ID: 9371598
[TBL] [Abstract][Full Text] [Related]
2. Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2.
Sugai J; Eiden M; Anderson MM; Van Hoeven N; Meiering CD; Overbaugh J
J Virol; 2001 Aug; 75(15):6841-9. PubMed ID: 11435563
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive approach to mapping the interacting surfaces of murine amphotropic and feline subgroup B leukemia viruses with their cell surface receptors.
Tailor CS; Nouri A; Kabat D
J Virol; 2000 Jan; 74(1):237-44. PubMed ID: 10590111
[TBL] [Abstract][Full Text] [Related]
4. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition.
Boomer S; Eiden M; Burns CC; Overbaugh J
J Virol; 1997 Nov; 71(11):8116-23. PubMed ID: 9343161
[TBL] [Abstract][Full Text] [Related]
5. Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses.
Anderson MM; Lauring AS; Robertson S; Dirks C; Overbaugh J
J Virol; 2001 Nov; 75(22):10563-72. PubMed ID: 11602698
[TBL] [Abstract][Full Text] [Related]
6. A 13-amino-acid Pit1-specific loop 4 sequence confers feline leukemia virus subgroup B receptor function upon Pit2.
Dreyer K; Pedersen FS; Pedersen L
J Virol; 2000 Mar; 74(6):2926-9. PubMed ID: 10684313
[TBL] [Abstract][Full Text] [Related]
7. Definition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor.
Battini JL; Danos O; Heard JM
J Virol; 1998 Jan; 72(1):428-35. PubMed ID: 9420242
[TBL] [Abstract][Full Text] [Related]
8. Feline leukemia virus infection requires a post-receptor binding envelope-dependent cellular component.
Hussain N; Thickett KR; Na H; Leung C; Tailor CS
J Virol; 2011 Dec; 85(23):12529-36. PubMed ID: 21917946
[TBL] [Abstract][Full Text] [Related]
9. Fusion-defective gibbon ape leukemia virus vectors can be rescued by homologous but not heterologous soluble envelope proteins.
Farrell KB; Ting YT; Eiden MV
J Virol; 2002 May; 76(9):4267-74. PubMed ID: 11932392
[TBL] [Abstract][Full Text] [Related]
10. Cellular and species resistance to murine amphotropic, gibbon ape, and feline subgroup C leukemia viruses is strongly influenced by receptor expression levels and by receptor masking mechanisms.
Tailor CS; Nouri A; Kabat D
J Virol; 2000 Oct; 74(20):9797-801. PubMed ID: 11000257
[TBL] [Abstract][Full Text] [Related]
11. Role of variable regions A and B in receptor binding domain of amphotropic murine leukemia virus envelope protein.
Han JY; Zhao Y; Anderson WF; Cannon PM
J Virol; 1998 Nov; 72(11):9101-8. PubMed ID: 9765455
[TBL] [Abstract][Full Text] [Related]
12. Genetic and biochemical analyses of receptor and cofactor determinants for T-cell-tropic feline leukemia virus infection.
Lauring AS; Cheng HH; Eiden MV; Overbaugh J
J Virol; 2002 Aug; 76(16):8069-78. PubMed ID: 12134012
[TBL] [Abstract][Full Text] [Related]
13. Distinctive receptor binding properties of the surface glycoprotein of a natural feline leukemia virus isolate with unusual disease spectrum.
Bolin LL; Chandhasin C; Lobelle-Rich PA; Albritton LM; Levy LS
Retrovirology; 2011 May; 8():35. PubMed ID: 21569491
[TBL] [Abstract][Full Text] [Related]
14. Identification of an extracellular domain within the human PiT2 receptor that is required for amphotropic murine leukemia virus binding.
Feldman SA; Farrell KB; Murthy RK; Russ JL; Eiden MV
J Virol; 2004 Jan; 78(2):595-602. PubMed ID: 14694091
[TBL] [Abstract][Full Text] [Related]
15. Chimeras of receptors for gibbon ape leukemia virus/feline leukemia virus B and amphotropic murine leukemia virus reveal different modes of receptor recognition by retrovirus.
Pedersen L; Johann SV; van Zeijl M; Pedersen FS; O'Hara B
J Virol; 1995 Apr; 69(4):2401-5. PubMed ID: 7884886
[TBL] [Abstract][Full Text] [Related]
16. Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants.
Lauring AS; Anderson MM; Overbaugh J
J Virol; 2001 Oct; 75(19):8888-98. PubMed ID: 11533152
[TBL] [Abstract][Full Text] [Related]
17. Amphotropic murine leukemia virus entry is determined by specific combinations of residues from receptor loops 2 and 4.
Lundorf MD; Pedersen FS; O'Hara B; Pedersen L
J Virol; 1999 Apr; 73(4):3169-75. PubMed ID: 10074169
[TBL] [Abstract][Full Text] [Related]
18. Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU.
Valsesia-Wittmann S; Morling FJ; Nilson BH; Takeuchi Y; Russell SJ; Cosset FL
J Virol; 1996 Mar; 70(3):2059-64. PubMed ID: 8627737
[TBL] [Abstract][Full Text] [Related]
19. Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum.
Chandhasin C; Coan PN; Levy LS
J Virol; 2005 Feb; 79(3):1351-60. PubMed ID: 15650161
[TBL] [Abstract][Full Text] [Related]
20. Structure and mechanism of a coreceptor for infection by a pathogenic feline retrovirus.
Barnett AL; Wensel DL; Li W; Fass D; Cunningham JM
J Virol; 2003 Feb; 77(4):2717-29. PubMed ID: 12552012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
